In a phase 3 study, patients who received recombinant ADAMTS13 did not experience acute TTP events during prophylaxis. How do you diagnose thrombotic thrombocytopenic purpura? The group points out clinical presentations. Researchers investigated patients with immune thrombotic thrombocytopenic purpura (iTTP) to identify predictive factors ... A recent study published in the British Journal of Haematology looked at immune thrombotic thrombocytopenic purpura ... The U.S. Food and Drug Administration approved caplacizumab-yhdp injection as the first treatment specifically indicated ...